title: QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation.
abstract: We assessed the feasibility of AliveCor tracings for QTC assessment in patients receiving dofetilide. Five patients with persistent AF underwent the two-handed measurement (mimicks Lead I). On the ECG, Lead I or II was used. There was no significant difference between the AliveCor-QTC and ECG-QTC (all ±20 msec). The AliveCor device can be used to monitor the QTC in these patients.
authors.affiliation: Division of Cardiology, Cardiac Electrophysiology, UNC School of Medicine, 160 Dental Circle, CB 7075, Chapel Hill, NC 27599 USA. Electronic address: ehchung@med.unc.edu.
authors.forename: Eugene H
authors.initials: EH
authors.lastname: Chung
authors.affiliation: Division of Cardiology, Cardiac Electrophysiology, UNC School of Medicine, 160 Dental Circle, CB 7075, Chapel Hill, NC 27599 USA.
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Guise
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000188:drug therapy*; D004562:Electrocardiography / Q000187:drug effects / Q000295:instrumentation*; D004867:Equipment Design; D019544:Equipment Failure Analysis; D006801:Humans; D063731:Mobile Applications; D010627:Phenethylamines / Q000627:therapeutic use*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D000068997:Smartphone; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D013449:Sulfonamides; C063533:dofetilide
keywords: AliveCor; Atrial fibrillation; ECG; QT interval; QTC